Form 13-F position report

CERO THERAPEUTICS HLDGS INC

Reported by SBI Securities Co Ltd

CERO CUSIP 71902K303 Manager CIK 0001851815

First reported at 5,523 shares this quarter.

New
% of reported 13F value < 0.01% This manager · Q4 2024
Shares 5,523 Quarter-end amount reported
Reported value $331 Fair value at quarter end
Consecutive quarters held 1 Through Q4 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2024-12-31 331
2025-03-31 80
2025-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

3 quarters
Quarterly reported position history for CERO THERAPEUTICS HLDGS INC held by SBI Securities Co Ltd.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2025 Reduced 0 -110 (-100.0%) 0 $0 2025-08-08
Q1 2025 Reduced 110 -5,413 (-98.0%) < 0.01% $80 2025-05-02
Q4 2024 New 5,523 +5,523 (0.0%) < 0.01% $331 2025-02-06

Who else reported the position

1 manager reported CERO THERAPEUTICS HLDGS INC for Q4 2024.

Managers reporting CERO THERAPEUTICS HLDGS INC in Q4 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
SBI Securities Co Ltd This report New 5,523 +5,523 < 0.01% $331 1 qtr
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2024
Filed
February 06, 2025
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
5,523
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.